HB 2144 - Expands Access to Biomarker Testing - Arizona Key Vote
Jennifer Pawlik voted Yea (Concurrence Vote) on this Legislation.
Timeline
- Executive Signed
- May 6, 2022
- House Concurrence Vote Passed
- May 2, 2022
- Senate Bill Passed
- April 25, 2022
- House Bill Passed
- Feb. 24, 2022
- Introduced
- Jan. 18, 2022
Related Issues
Stage Details
Title: Expands Access to Biomarker Testing
Signed by Governor Doug Ducey
Title: Expands Access to Biomarker Testing
Highlights:
-
Specifies that a subscription contract shall cover biomarker testing for the purposes of diagnosis, treatment, appropriate management or ongoing monitoring of a subscriber’s disease or condition to guide treatment decisions (Sec. 1).
Title: Expands Access to Biomarker Testing
Highlights:
-
Specifies that a subscription contract shall cover biomarker testing for the purposes of diagnosis, treatment, appropriate management or ongoing monitoring of a subscriber’s disease or condition to guide treatment decisions (Sec. 1).
Title: Expands Access to Biomarker Testing
Title: Expands Access to Biomarker Testing